Claims
- 1. A pharmaceutical or veterinary composition comprising an olefinic compound of the formula:
- R.sup.1 R.sup.2 R.sup.3 C--CR.sup.4 .dbd.CR.sup.5 R.sup.6 (I)
- wherein R.sup.1 is 1,2,4-triazolyl; R.sup.2 and R.sup.3, which may be the same or different, are each a hydrogen atom or a 1-6C alkyl radical; R.sup.4 is phenyl radical, optionally bearing one or more substituents selected from halogen atoms, amino, cyano, carbamoyl and nitro radicals, 1-6C alkyl, halogenoalkyl, alkoxy, halogenoalkoxy, alkylamino and alkylcarbamoyl radicals, di(1-6C alkyl)amino, di(1-6C alkyl)carbamoyl and 2-6C alkoxycarbonyl radicals; R.sup.5 is a hydrogen or halogen atom, a 1-6C alkyl radical or a phenyl radical optionally bearing one or more substituents as defined above for R.sup.4 ; and R.sup.6 is a phenyl radical optionally bearing one or more substituents as defined above for R.sup.4 ; or, for those compounds which contain a basic nitrogen atom, the pharmaceutically or veterinarily acceptable salts thereof, together with a pharmaceutically or veterinarily acceptable diluent or carrier, but excluding a composition in the form of a non-sterile solution, emulsion, emulsifiable concentrate, suspension, powder, paste, or granule.
- 2. A pharmaceutical or veterinary composition in dosage unit form comprising an olefinic compound of the formula:
- R.sup.1 R.sup.2 R.sup.3 C--CR.sup.4 .dbd.CR.sup.5 R.sup.6 (I)
- wherein R.sup.1 is 1,2,4-triazolyl; R.sup.2 and R.sup.3, which may be the same or different, are each a hydrogen atom or a 1-6C alkyl radical; R.sup.4 is a phenyl radical, optionally bearing one or more substituents selected from halogen atoms, amino, cyano, carbamoyl and nitro radicals, 1-6C alkyl, halogenoalkyl, alkoxy, halogenoalkoxy, alkylamino and alkylcarbamoyl radicals, di(1-6C alkyl)amino, di(1-6C alkyl)carbamoyl and 2-6C alkoxycarbonyl radicals, R.sup.5 is a hydrogen or halogen atom, a 1-6C alkyl radical or phenyl radical optionally bearing one or more substituents as defined above for R.sup.4 ; and R.sup.6 is a phenyl radical optionally bearing one or more substituents as defined above for R.sup.4 ; or, for those compounds which contain a basic nitrogen atom, the pharmaceutically or veterinarily acceptable salts thereof, together with a pharmaceutically or veterinarily acceptable diluent or carrier.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8716650 |
Jul 1987 |
GBX |
|
Parent Case Info
This is a division of application Ser. No. 07/218,246, filed 7/13/88 now U.S. Pat. No. 4,866,086, issued on Sept. 12, 1989.
US Referenced Citations (9)
Non-Patent Literature Citations (2)
Entry |
Chemical Abstracts Service, CA100(7):51583h, Abstract of DE 3210570, Oct. 6, 1983, (Ehrhardt). |
Chemical Abstracts Service, CA89(13):109507;, Abstract of DE 2652313, May 18, 1978, (Pommer). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
218246 |
Jul 1988 |
|